Jeff Liter is listed as an executive officer, director, and promoter on 11 SEC Form D filings by 3 issuers between May 2016 and Nov 2025: Luminary Therapeutics, Inc. (Minneapolis, MN — biotechnology — 2019–2025; $5.22M reported sold to 49 investors), B-MoGen Biotechnologies, Inc. (St. Paul, MN — biotechnology — 2016; $1.03M reported sold to 8 investors) and OX2 Therapeutics, Inc. (Minneapolis, MN — biotechnology — 2017–2020; $649K reported sold to 15 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, director, and promoter, over about 9 years. Across those companies the filings report $6.9M sold in total.
Listed alongside John Wells (7 shared filings), Tracey Lodie (7 shared filings), David Largaespada (6 shared filings), James Haymaker (5 shared filings), Mark Chance (5 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jeff. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 7 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 9 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 11 public filings for Jeff Liter and found 8 differences, 1 worth asking the sponsor about: 7 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.